Healthcare

● PLSE closed Friday, October 9, 2026, at $53.81, up 7.66%, among the stronger US gainers of the session.

Humana (NYSE:HUM) was the clear winner of the CMS release. The agency restored a 4-star rating to its flagshipMedicareAdvantage contract, numbered H5216, which covers over 2 million members. The stock closed up 11.56%, while intraday gains of 12% to 14% appear in other data, …

Moderna (NASDAQ:MRNA) is the one name with a verified event. TheNasdaqannounced that the company would rejoin the Nasdaq-100, and the stock rose as much as 14% on October 9, 2026, although reports of the move range from 5% to 14% depending on the timing …

Medicare Advantage plans are scored by CMS on a five-star scale covering clinical quality, member experience and plan operations. Plans rated 4 stars or higher earn qualityBonuspayments and a larger rebate share, and rebates fund extra benefits such as lower premiums, dental and vision …

Star ratings drive Medicare Advantage economics. Plans rated 4 stars or higher earn qualityBonuspayments, and they receive a larger share of rebates that fund richer benefits such as lower premiums and extra coverage. A single large contract matters because Humana (NYSE:HUM) concentrates a large …

Alignment Healthcare (NASDAQ:ALHC) operates Medicare Advantage plans and has built itsMarketingaround high quality ratings. A drop in its 4-star member share from 100% to 25% is therefore a direct hit to the case investors had been paying for. Plans rated 4 stars or higher …

CVS Health (NYSE:CVS) owns Aetna, one of the largestMedicareAdvantage insurers, together with a pharmacy chain and a pharmacy benefit manager. A decline of about 3.2% after the ratings news is modest compared with the double-digit moves at Humana and Alignment, which suggests investors saw …